Vaccine development usually spans a number of decades. This is because there’s a need to understand the mechanisms of protection against the pathogen, and to minimise adverse reactions.
Countries closed their borders in response to COVID-19, but international cooperation and technology sharing could improve recovery against pandemics and potential bioterrorist attacks.
As the COVID-19 pandemic exacerbates global economic and health insecurities, opportunities to emulate the pandemic’s effects with bioweapons affords terrorists a new model.
Fundamental research has informed what we know about coronaviruses up until the pandemic. With possible future outbreaks, continuing and developing this type of work is crucial.
The variation captured in these genomes, when compared to genomes sampled elsewhere, provides a fingerprint that might be associated with a particular virus and a particular cluster of transmission.
Information collected from DNA samples can be used to identify species, track their movements and diagnose genetic diseases. This information is useful in conservation and management projects.
A landmark analysis of the genetic sequences of hundreds of different cancers offers crucial insights into the origins and growth of the disease’s myriad forms.
Through genetic detective work, scientists have identified missing links in the tomato’s evolution from a wild blueberry-sized fruit in South America to the larger modern tomato of today.
Trust in our global food supply chains remains a concern. For the foreseeable future, much of Canada’s food fraud remains hidden in plain sight, sitting right there on our grocery store shelves.
The scientist who announced the world’s first genome-edited twins received a prison sentence and a large fine for his research. But the systems that enabled him have not been held to account.
DNA testing kits will be a popular gift this holiday season. Before mailing off your saliva, it’s important to understand what these kits can and cannot tell us.
One year after the first CRISPR babies were announced, changes in policies and regulations have meant that there have been no new CRISPR announcements since.